Our finding that the ISG15‐γ‐GCL‐glutothione axis may prevent ROS‐induced apoptosis in HCC cells thus offers a new target for therapy against NRF2 inhibition insensitive cancers like HCC.[47]. This evidence concerns the gene GCLC and hepatocellular carcinoma.